Public research summary

SYK Stock Analysis: Stryker Corp

Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degen

Data through Sep 8, 2026
Latest close
$275.39
20-day change
-13.24%
Trend state
BEARISH
Classification
Healthcare · Medical - Devices

Market context

Stryker Corp moved -13.24% over the latest 20-session window. BullRecon currently classifies the broader setup as BEARISH.

Latest report

The latest cached company filing period (FY2025 · $25.1B revenue · $3.2B net income) is used alongside annual and quarterly history. Values remain tied to their reported period.

Six-dimension read

Quality is currently the strongest dimension at 5.6/6, while Value is the lowest at 4.0/6. Scores are comparative research signals, not forecasts.

Value 4.0/6
Growth 4.4/6
Quality 5.6/6
Profitability 4.8/6
Health 4.6/6
Future 4.2/6
Built from cached market data, company filings and transparent rule-based calculations. Automated research is informational and is not investment advice.

Loading the interactive report and checking your access…